Tate & Lyle PLC (Tate & Lyle) is a global leader in providing specialty food and beverage solutions, focusing on sweetening, mouthfeel, and fortification. The company transforms raw materials such as corn, tapioca, and stevia into high-value ingredients that enhance the taste, texture, and nutritional value of food and beverages.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Tate & Lyle places a strong emphasis on research and development (R&D) to lead in the food and beverage solutions industry. The company operates a robust innovation process that combines in-house development with external open innovation. This approach has resulted in a strong pipeline of new ingredients and solutions tailored to meet customer needs. Tate & Lyle's Platform and Solutions Development team closely monitors consumer and category trends, working with commercial partners to ensure that new products align with market demands. The integration of the Tate & Lyle and CP Kelco Science and Innovation teams has significantly enhanced the company's scientific and applications expertise. As of March, Tate & Lyle's innovation efforts are supported by a comprehensive patent portfolio, which includes 958 patents granted and 271 pending. The company continues to invest in new technologies to enhance its processes, such as the development of an AI tool that searches technical and scientific libraries to provide faster formulation recommendations. Additionally, Tate & Lyle has launched eight new solutions chassis during the year, which serve as the global foundation for developing bespoke solutions for customers in different regions. In FY2026, the company incurred expenses of GBP62 million on its R&D, which as a percentage of revenue, stood at 3.1%.